Literature DB >> 26719287

Mosla scabra flavonoids ameliorate the influenza A virus-induced lung injury and water transport abnormality via the inhibition of PRR and AQP signaling pathways in mice.

Chen-Huan Yu1, Wen-Ying Yu1, Jie Fang1, Huan-Huan Zhang1, Yue Ma1, Bing Yu2, Fang Wu3, Xiao-Ning Wu4.   

Abstract

ETHNOPHARMACROLOGICAL RELEVANCE: Mosla scabra (Thunb.) C.Y. Wu and H.W. Li has been used as a traditional medicinal herb for centuries in East Asian countries. It has antibacterial, antiviral, antioxidant, anti-inflammatory and immunomodulatory effects. In folk medicine, it is used as a remedy for the treatment of pulmonary diseases, such as fever, cold, cough, pulmonary edema and emphysema. AIM OF THE STUDY: This study was to investigate the protective mechanism of total flavonoids from M. scabra (MF) in influenza A virus (IAV)-infected mice.
MATERIALS AND METHODS: The mice were infected with IAV and then were treated daily with MF for five days. At the end of the experiment, the levels of inflammatory-related cytokines (IFN-α, IL-6, TNF-α and IL-1β) were determined by ELISA. Pathological changes of lung tissue were examined by H&E staining. The protein expressions of AQP5, p-p38, caspase-3 and NF-κB p65 were detected by western blot analysis while the gene expressions of key effectors in AQP5 and PRRs signaling pathways were detected by real-time Fluorescence Quantitative Polymerase Chain Reaction (RFQ-PCR) analysis.
RESULTS: The results showed that treatment with MF at doses of 120-360mg/kg for five days to IAV-infected mice significantly attenuated IAV-induced pulmonary injury and decreased the serum levels of IL-6, TNF-α and IL-1β, but increased IFN-α levels. MF treatment could up-regulate the mRNA expressions of TLR-7, RIG-1, TRAF6, Bcl-2, Bax, VIPR1, PKCα and AQP5 and down-regulate caspase-3 and NF-κB p65 protein expression.
CONCLUSION: Treatment with MF could significantly alleviate IAV-induced pulmonary inflammation, apoptosis and water transport abnormality, which was probably through the regulation of TLR7, RIG-1 and AQP5 signaling pathway.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antiviral; Apoptosis; Aquaporin 5; Inflammation; Vasoactive intestinal peptide

Mesh:

Substances:

Year:  2015        PMID: 26719287     DOI: 10.1016/j.jep.2015.12.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

Review 1.  Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.

Authors:  Chrysi Keskinidou; Alice G Vassiliou; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  J Inflamm Res       Date:  2022-06-15

2.  Anti-Inflammatory Mechanisms of Total Flavonoids from Mosla scabra against Influenza A Virus-Induced Pneumonia by Integrating Network Pharmacology and Experimental Verification.

Authors:  Wei Cai; Shui-Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

3.  Antiviral activities of atractylon from Atractylodis Rhizoma.

Authors:  Yang Cheng; Jing-Yin Mai; Tian-Lu Hou; Jian Ping; Jian-Jie Chen
Journal:  Mol Med Rep       Date:  2016-09-05       Impact factor: 2.952

4.  Cirsimaritin inhibits influenza A virus replication by downregulating the NF-κB signal transduction pathway.

Authors:  Haiyan Yan; Huiqiang Wang; Linlin Ma; Xueping Ma; Jinqiu Yin; Shuo Wu; Hua Huang; Yuhuan Li
Journal:  Virol J       Date:  2018-05-21       Impact factor: 4.099

5.  Lignans from Mosla scabra Ameliorated Influenza A Virus-Induced Pneumonia via Inhibiting Macrophage Activation.

Authors:  Wei Cai; Li-Ren Wu; Shui-Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-30       Impact factor: 2.650

Review 6.  Aquaporins as Targets of Dietary Bioactive Phytocompounds.

Authors:  Angela Tesse; Elena Grossini; Grazia Tamma; Catherine Brenner; Piero Portincasa; Raul A Marinelli; Giuseppe Calamita
Journal:  Front Mol Biosci       Date:  2018-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.